Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia.
Nakasone H, Kanda Y, Takasaki H, Nakaseko C, Sakura T, Fujisawa S, Yokota A, Yano S, Usuki K, Maruta A, Abe D, Hoshino T, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy. Nakasone H, et al. Among authors: yano s. Leukemia. 2010 Jun;24(6):1236-9. doi: 10.1038/leu.2010.83. Epub 2010 Apr 29. Leukemia. 2010. PMID: 20428195 No abstract available.
Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.
Motohashi K, Fujisawa S, Onizuka M, Kako S, Sakaida E, Shono K, Tatara R, Doki N, Mori T, Sakura T, Aotsuka N, Fuji E, Tomita N, Kawai N, Saitoh T, Usuki K, Taguchi J, Watanabe R, Kobayashi S, Yano S, Kanamori H, Takahashi S, Okamoto S. Motohashi K, et al. Among authors: yano s. Bone Marrow Transplant. 2015 Nov;50(11):1476-9. doi: 10.1038/bmt.2015.142. Epub 2015 Jul 20. Bone Marrow Transplant. 2015. PMID: 26191948 No abstract available.
Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma.
Yano S, Mori T, Kanda Y, Kato J, Nakaseko C, Fujisawa S, Tomita N, Sakai R, Shono K, Saitoh T, Aotsuka N, Kobayashi N, Saito T, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Yano S, et al. Bone Marrow Transplant. 2015 Oct;50(10):1299-305. doi: 10.1038/bmt.2015.158. Epub 2015 Jul 13. Bone Marrow Transplant. 2015. PMID: 26168068
Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.
Tanaka M, Kanamori H, Matsumoto K, Tachibana T, Numata A, Ohashi K, Kobayashi T, Nakaseko C, Kanda Y, Yamazaki E, Fujisawa S, Ooi J, Sakura T, Aotsuka N, Onoda M, Machida S, Kato J, Usuki K, Watanabe R, Taguchi J, Yano S, Saito T, Takahashi S, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy. Tanaka M, et al. Among authors: yano s. Bone Marrow Transplant. 2015 May;50(5):727-33. doi: 10.1038/bmt.2015.17. Epub 2015 Mar 2. Bone Marrow Transplant. 2015. PMID: 25730191 Clinical Trial.
Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation.
Yanada M, Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, Usuki K, Kobayashi T, Watanabe M, Nagafuji K, Yano S, Nawa Y, Tomiyama J, Tashiro H, Nakamura Y, Fujisawa S, Kimura F, Emi N, Miura I, Fukuda T. Yanada M, et al. Among authors: yano s. Bone Marrow Transplant. 2013 Mar;48(3):390-5. doi: 10.1038/bmt.2012.159. Epub 2012 Sep 3. Bone Marrow Transplant. 2013. PMID: 22941379
Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M; GVHD working group of the Japan Society of Hematopoietic Cell Transplantation. Nakasone H, et al. Among authors: yano s. Bone Marrow Transplant. 2015 Apr;50(4):559-65. doi: 10.1038/bmt.2014.293. Epub 2014 Dec 22. Bone Marrow Transplant. 2015. PMID: 25531281 Clinical Trial.
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study.
Yanada M, Kurosawa S, Kobayashi T, Ozawa Y, Kanamori H, Kobayashi N, Sawa M, Nakamae H, Uchida N, Hashimoto H, Fukuda T, Hirokawa M, Atsuta Y, Yano S. Yanada M, et al. Among authors: yano s. Bone Marrow Transplant. 2017 Jun;52(6):818-824. doi: 10.1038/bmt.2016.358. Epub 2017 Jan 23. Bone Marrow Transplant. 2017. PMID: 28112749 Clinical Trial.
Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML.
Aoki J, Seo S, Kanamori H, Tanaka M, Fukuda T, Onizuka M, Kobayashi N, Kondo T, Sawa M, Uchida N, Iwato K, Icihnohe T, Atsuta Y, Yano S, Takami A. Aoki J, et al. Among authors: yano s. Bone Marrow Transplant. 2016 Apr;51(4):604-6. doi: 10.1038/bmt.2015.297. Epub 2015 Dec 7. Bone Marrow Transplant. 2016. PMID: 26642343 No abstract available.
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study.
Kim SW, Mori SI, Tanosaki R, Fukuda T, Kami M, Sakamaki H, Yamashita T, Kodera Y, Terakura S, Taniguchi S, Miyakoshi S, Usui N, Yano S, Kawano Y, Nagatoshi Y, Harada M, Morishima Y, Okamoto S, Saito AM, Ohashi Y, Ueda R, Takaue Y. Kim SW, et al. Among authors: yano s. Bone Marrow Transplant. 2009 Apr;43(8):611-7. doi: 10.1038/bmt.2008.372. Epub 2008 Nov 17. Bone Marrow Transplant. 2009. PMID: 19011665 Clinical Trial.
2,529 results